Overview

An Extension of the CONCERT Protocol (DIM18)

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

An open-label extension study of the CONCERT (DIM18) protocol evaluating the safety of dimebon (latrepirdine) in subjects with With Mild-to-Moderate Alzheimer's Disease on Donepezil.

Phase:

Phase 3

Details

Lead Sponsor:

Medivation, Inc.

Collaborator:

Pfizer